ACTINIUM PHARMACEUTICALS, INC. FORM 8-K

Company

Actinium Pharmaceuticals, Inc.

Filed

December 24, 2014

Period of Report

December 22, 2014

Accession Number

0001213900-14-009129

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →